Reports

Industry Research Reports

Membrane Filtration Pharmaceutical Sterility Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Membrane Filtration Pharmaceutical Sterility Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-03-11

Pages: 94 Pages

Report ld: 4639911

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global market for Membrane Filtration Pharmaceutical Sterility Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

rile, enclosed units allow for the simultaneous filtration of equal volumes of test samples through two membrane filters. Samples are incubated in two types of media for 14 days, facilitating the detection of both aerobic and anaerobic microorganisms.

North American market for Membrane Filtration Pharmaceutical Sterility Testing was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Membrane Filtration Pharmaceutical Sterility Testing was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Membrane Filtration Pharmaceutical Sterility Testing was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Membrane Filtration Pharmaceutical Sterility Testing include Steris PLC, Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., SGS S.A., Sartorius AG, Sotera Health Company, Pacific Biolabs, Inc., Laboratory Corporation of America Holdings, Almac Group, Pace Analytical Services, LLC, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Membrane Filtration Pharmaceutical Sterility Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Membrane Filtration Pharmaceutical Sterility Testing by region & country, by Type, and by Application.

The Membrane Filtration Pharmaceutical Sterility Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Membrane Filtration Pharmaceutical Sterility Testing.

MARKET SEGMENTATION

By Company

  • Steris PLC
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.
  • SGS S.A.
  • Sartorius AG
  • Sotera Health Company
  • Pacific Biolabs, Inc.
  • Laboratory Corporation of America Holdings
  • Almac Group
  • Pace Analytical Services, LLC

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Bioburden Testing
  • Sterility Testing
  • Bacterial Endotoxin Testing

Segment by Application

  • Pharmaceuticals
  • Medical Devices
  • Biopharmaceuticals

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 2: Detailed analysis of Membrane Filtration Pharmaceutical Sterility Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 5: Revenue of Membrane Filtration Pharmaceutical Sterility Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 6: Revenue of Membrane Filtration Pharmaceutical Sterility Testing in country level. It provides sigmate data by Type, and by Application for each country/region.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Membrane Filtration Pharmaceutical Sterility Testing Product Introduction

1.2 Global Membrane Filtration Pharmaceutical Sterility Testing Market Size Forecast (2020-2031)

1.3 Membrane Filtration Pharmaceutical Sterility Testing Market Trends & Drivers

1.3.1 Membrane Filtration Pharmaceutical Sterility Testing Industry Trends

1.3.2 Membrane Filtration Pharmaceutical Sterility Testing Market Drivers & Opportunity

1.3.3 Membrane Filtration Pharmaceutical Sterility Testing Market Challenges

1.3.4 Membrane Filtration Pharmaceutical Sterility Testing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Membrane Filtration Pharmaceutical Sterility Testing Players Revenue Ranking (2024)

2.2 Global Membrane Filtration Pharmaceutical Sterility Testing Revenue by Company (2020-2025)

2.3 Key Companies Membrane Filtration Pharmaceutical Sterility Testing Manufacturing Base Distribution and Headquarters

2.4 Key Companies Membrane Filtration Pharmaceutical Sterility Testing Product Offered

2.5 Key Companies Time to Begin Mass Production of Membrane Filtration Pharmaceutical Sterility Testing

2.6 Membrane Filtration Pharmaceutical Sterility Testing Market Competitive Analysis

2.6.1 Membrane Filtration Pharmaceutical Sterility Testing Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Membrane Filtration Pharmaceutical Sterility Testing Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Membrane Filtration Pharmaceutical Sterility Testing as of 2024)

2.7 Mergers & Acquisitions, Expansion

muLu

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Bioburden Testing

3.1.2 Sterility Testing

3.1.3 Bacterial Endotoxin Testing

3.2 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type

3.2.1 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value, by Type (2020-2031)

3.2.3 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value, by Type (%) (2020-2031)

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pharmaceuticals

4.1.2 Medical Devices

4.1.3 Biopharmaceuticals

4.2 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application

4.2.1 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value, by Application (2020-2031)

4.2.3 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value, by Application (%) (2020-2031)

muLu

5 Segmentation by Region

5.1 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region

5.1.1 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region (2020-2025)

5.1.3 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region (2026-2031)

5.1.4 Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

5.2.2 North America Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

5.3.2 Europe Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

5.4.2 Asia Pacific Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

5.5.2 South America Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

5.6.2 Middle East & Africa Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Country (%), 2024 VS 2031

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Membrane Filtration Pharmaceutical Sterility Testing Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

6.3 United States

6.3.1 United States Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

6.3.2 United States Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

6.4.2 Europe Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

6.5.2 China Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031

6.5.3 China Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

6.6.2 Japan Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

6.7.2 South Korea Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

6.8.2 Southeast Asia Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020-2031

6.9.2 India Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031

6.9.3 India Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application, 2024 VS 2031

muLu

7 Company Profiles

7.1 Steris PLC

7.1.1 Steris PLC Profile

7.1.2 Steris PLC Main Business

7.1.3 Steris PLC Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions

7.1.4 Steris PLC Membrane Filtration Pharmaceutical Sterility Testing Revenue (US$ Million) & (2020-2025)

7.1.5 Steris PLC Recent Developments

7.2 Charles River Laboratories International, Inc.

7.2.1 Charles River Laboratories International, Inc. Profile

7.2.2 Charles River Laboratories International, Inc. Main Business

7.2.3 Charles River Laboratories International, Inc. Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions

7.2.4 Charles River Laboratories International, Inc. Membrane Filtration Pharmaceutical Sterility Testing Revenue (US$ Million) & (2020-2025)

7.2.5 Charles River Laboratories International, Inc. Recent Developments

7.3 Thermo Fisher Scientific, Inc.

7.3.1 Thermo Fisher Scientific, Inc. Profile

7.3.2 Thermo Fisher Scientific, Inc. Main Business

7.3.3 Thermo Fisher Scientific, Inc. Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions

7.3.4 Thermo Fisher Scientific, Inc. Membrane Filtration Pharmaceutical Sterility Testing Revenue (US$ Million) & (2020-2025)

7.3.5 Thermo Fisher Scientific, Inc. Recent Developments

7.4 SGS S.A.

7.4.1 SGS S.A. Profile

7.4.2 SGS S.A. Main Business

7.4.3 SGS S.A. Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions

7.4.4 SGS S.A. Membrane Filtration Pharmaceutical Sterility Testing Revenue (US$ Million) & (2020-2025)

7.4.5 SGS S.A. Recent Developments

7.5 Sartorius AG

7.5.1 Sartorius AG Profile

7.5.2 Sartorius AG Main Business

7.5.3 Sartorius AG Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions

7.5.4 Sartorius AG Membrane Filtration Pharmaceutical Sterility Testing Revenue (US$ Million) & (2020-2025)

7.5.5 Sartorius AG Recent Developments

7.6 Sotera Health Company

7.6.1 Sotera Health Company Profile

7.6.2 Sotera Health Company Main Business

7.6.3 Sotera Health Company Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions

7.6.4 Sotera Health Company Membrane Filtration Pharmaceutical Sterility Testing Revenue (US$ Million) & (2020-2025)

7.6.5 Sotera Health Company Recent Developments

7.7 Pacific Biolabs, Inc.

7.7.1 Pacific Biolabs, Inc. Profile

7.7.2 Pacific Biolabs, Inc. Main Business

7.7.3 Pacific Biolabs, Inc. Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions

7.7.4 Pacific Biolabs, Inc. Membrane Filtration Pharmaceutical Sterility Testing Revenue (US$ Million) & (2020-2025)

7.7.5 Pacific Biolabs, Inc. Recent Developments

7.8 Laboratory Corporation of America Holdings

7.8.1 Laboratory Corporation of America Holdings Profile

7.8.2 Laboratory Corporation of America Holdings Main Business

7.8.3 Laboratory Corporation of America Holdings Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions

7.8.4 Laboratory Corporation of America Holdings Membrane Filtration Pharmaceutical Sterility Testing Revenue (US$ Million) & (2020-2025)

7.8.5 Laboratory Corporation of America Holdings Recent Developments

7.9 Almac Group

7.9.1 Almac Group Profile

7.9.2 Almac Group Main Business

7.9.3 Almac Group Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions

7.9.4 Almac Group Membrane Filtration Pharmaceutical Sterility Testing Revenue (US$ Million) & (2020-2025)

7.9.5 Almac Group Recent Developments

7.10 Pace Analytical Services, LLC

7.10.1 Pace Analytical Services, LLC Profile

7.10.2 Pace Analytical Services, LLC Main Business

7.10.3 Pace Analytical Services, LLC Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions

7.10.4 Pace Analytical Services, LLC Membrane Filtration Pharmaceutical Sterility Testing Revenue (US$ Million) & (2020-2025)

7.10.5 Pace Analytical Services, LLC Recent Developments

muLu

8 Industry Chain Analysis

8.1 Membrane Filtration Pharmaceutical Sterility Testing Industrial Chain

8.2 Membrane Filtration Pharmaceutical Sterility Testing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Membrane Filtration Pharmaceutical Sterility Testing Sales Model

8.5.2 Sales Channel

8.5.3 Membrane Filtration Pharmaceutical Sterility Testing Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Membrane Filtration Pharmaceutical Sterility Testing Market Trends
Table 2. Membrane Filtration Pharmaceutical Sterility Testing Market Drivers & Opportunity
Table 3. Membrane Filtration Pharmaceutical Sterility Testing Market Challenges
Table 4. Membrane Filtration Pharmaceutical Sterility Testing Market Restraints
Table 5. Global Membrane Filtration Pharmaceutical Sterility Testing Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Membrane Filtration Pharmaceutical Sterility Testing Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Membrane Filtration Pharmaceutical Sterility Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Membrane Filtration Pharmaceutical Sterility Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Membrane Filtration Pharmaceutical Sterility Testing
Table 10. Global Membrane Filtration Pharmaceutical Sterility Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Membrane Filtration Pharmaceutical Sterility Testing as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Market Share in Value by Type (2020-2025)
Table 17. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Market Share in Value by Type (2026-2031)
Table 18. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Market Share in Value by Application (2020-2025)
Table 22. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Market Share in Value by Application (2026-2031)
Table 23. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region (2020-2025) & (%)
Table 27. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Membrane Filtration Pharmaceutical Sterility Testing Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2026-2031) & (US$ Million)
Table 31. Steris PLC Basic Information List
Table 32. Steris PLC Description and Business Overview
Table 33. Steris PLC Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Membrane Filtration Pharmaceutical Sterility Testing Business of Steris PLC (2020-2025)
Table 35. Steris PLC Recent Developments
Table 36. Charles River Laboratories International, Inc. Basic Information List
Table 37. Charles River Laboratories International, Inc. Description and Business Overview
Table 38. Charles River Laboratories International, Inc. Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Membrane Filtration Pharmaceutical Sterility Testing Business of Charles River Laboratories International, Inc. (2020-2025)
Table 40. Charles River Laboratories International, Inc. Recent Developments
Table 41. Thermo Fisher Scientific, Inc. Basic Information List
Table 42. Thermo Fisher Scientific, Inc. Description and Business Overview
Table 43. Thermo Fisher Scientific, Inc. Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Membrane Filtration Pharmaceutical Sterility Testing Business of Thermo Fisher Scientific, Inc. (2020-2025)
Table 45. Thermo Fisher Scientific, Inc. Recent Developments
Table 46. SGS S.A. Basic Information List
Table 47. SGS S.A. Description and Business Overview
Table 48. SGS S.A. Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Membrane Filtration Pharmaceutical Sterility Testing Business of SGS S.A. (2020-2025)
Table 50. SGS S.A. Recent Developments
Table 51. Sartorius AG Basic Information List
Table 52. Sartorius AG Description and Business Overview
Table 53. Sartorius AG Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Membrane Filtration Pharmaceutical Sterility Testing Business of Sartorius AG (2020-2025)
Table 55. Sartorius AG Recent Developments
Table 56. Sotera Health Company Basic Information List
Table 57. Sotera Health Company Description and Business Overview
Table 58. Sotera Health Company Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Membrane Filtration Pharmaceutical Sterility Testing Business of Sotera Health Company (2020-2025)
Table 60. Sotera Health Company Recent Developments
Table 61. Pacific Biolabs, Inc. Basic Information List
Table 62. Pacific Biolabs, Inc. Description and Business Overview
Table 63. Pacific Biolabs, Inc. Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Membrane Filtration Pharmaceutical Sterility Testing Business of Pacific Biolabs, Inc. (2020-2025)
Table 65. Pacific Biolabs, Inc. Recent Developments
Table 66. Laboratory Corporation of America Holdings Basic Information List
Table 67. Laboratory Corporation of America Holdings Description and Business Overview
Table 68. Laboratory Corporation of America Holdings Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Membrane Filtration Pharmaceutical Sterility Testing Business of Laboratory Corporation of America Holdings (2020-2025)
Table 70. Laboratory Corporation of America Holdings Recent Developments
Table 71. Almac Group Basic Information List
Table 72. Almac Group Description and Business Overview
Table 73. Almac Group Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Membrane Filtration Pharmaceutical Sterility Testing Business of Almac Group (2020-2025)
Table 75. Almac Group Recent Developments
Table 76. Pace Analytical Services, LLC Basic Information List
Table 77. Pace Analytical Services, LLC Description and Business Overview
Table 78. Pace Analytical Services, LLC Membrane Filtration Pharmaceutical Sterility Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Membrane Filtration Pharmaceutical Sterility Testing Business of Pace Analytical Services, LLC (2020-2025)
Table 80. Pace Analytical Services, LLC Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Membrane Filtration Pharmaceutical Sterility Testing Downstream Customers
Table 84. Membrane Filtration Pharmaceutical Sterility Testing Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Membrane Filtration Pharmaceutical Sterility Testing Product Picture
Figure 2. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value (2020-2031) & (US$ Million)
Figure 4. Membrane Filtration Pharmaceutical Sterility Testing Report Years Considered
Figure 5. Global Membrane Filtration Pharmaceutical Sterility Testing Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Membrane Filtration Pharmaceutical Sterility Testing Revenue in 2024
Figure 7. Membrane Filtration Pharmaceutical Sterility Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Bioburden Testing Picture
Figure 9. Sterility Testing Picture
Figure 10. Bacterial Endotoxin Testing Picture
Figure 11. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Pharmaceuticals
Figure 14. Product Picture of Medical Devices
Figure 15. Product Picture of Biopharmaceuticals
Figure 16. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Membrane Filtration Pharmaceutical Sterility Testing Sales Value Market Share by Application, 2024 & 2031
Figure 18. North America Membrane Filtration Pharmaceutical Sterility Testing Sales Value (2020-2031) & (US$ Million)
Figure 19. North America Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Country (%), 2024 VS 2031
Figure 20. Europe Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2031) & (US$ Million)
Figure 21. Europe Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Country (%), 2024 VS 2031
Figure 22. Asia Pacific Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2031) & (US$ Million)
Figure 23. Asia Pacific Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Region (%), 2024 VS 2031
Figure 24. South America Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2031) & (US$ Million)
Figure 25. South America Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Country (%), 2024 VS 2031
Figure 26. Middle East & Africa Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2031) & (US$ Million)
Figure 27. Middle East & Africa Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Country (%), 2024 VS 2031
Figure 28. Key Countries/Regions Membrane Filtration Pharmaceutical Sterility Testing Sales Value (%), (2020-2031)
Figure 29. United States Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2031) & (US$ Million)
Figure 30. United States Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031
Figure 31. United States Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application (%), 2024 VS 2031
Figure 32. Europe Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2031) & (US$ Million)
Figure 33. Europe Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031
Figure 34. Europe Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application (%), 2024 VS 2031
Figure 35. China Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2031) & (US$ Million)
Figure 36. China Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031
Figure 37. China Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application (%), 2024 VS 2031
Figure 38. Japan Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2031) & (US$ Million)
Figure 39. Japan Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031
Figure 40. Japan Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application (%), 2024 VS 2031
Figure 41. South Korea Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2031) & (US$ Million)
Figure 42. South Korea Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031
Figure 43. South Korea Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application (%), 2024 VS 2031
Figure 44. Southeast Asia Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031
Figure 46. Southeast Asia Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application (%), 2024 VS 2031
Figure 47. India Membrane Filtration Pharmaceutical Sterility Testing Sales Value, (2020-2031) & (US$ Million)
Figure 48. India Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Type (%), 2024 VS 2031
Figure 49. India Membrane Filtration Pharmaceutical Sterility Testing Sales Value by Application (%), 2024 VS 2031
Figure 50. Membrane Filtration Pharmaceutical Sterility Testing Industrial Chain
Figure 51. Membrane Filtration Pharmaceutical Sterility Testing Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Membrane Filtration Pharmaceutical Sterility Testing market?zhanKai
The top companies in the global Membrane Filtration Pharmaceutical Sterility Testing market are Steris PLC、Charles River Laboratories International, Inc.、Thermo Fisher Scientific, Inc..
den_biaoTiZhungShi

Related Reports

Membrane Filtration Pharmaceutical Sterility Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-03-11

Pages: 94 Pages

Report ld: 4639911

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now